Stories
Prime Together Foundation selects 2022 grant recipients
Grants awarded to 13 organizations working to address inequity and improve health disparities
December 20, 2022![Blue Banner Featuring Image of Woman and Young Girl Affectionately Hugging One Another and Smiling](https://www.primetherapeutics.com/wp-content/uploads/2022/12/7289-C_Newsroom-BN_Foundation_1116x325B.png)
In its second cycle of charitable giving, the Prime Together Foundation recently awarded $170,000 in grants to 13 nonprofit organizations across the United States.
Organizations were selected based on how well they align with the Foundation’s mission to work together with communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger.
“We are proud to award our next cycle of grants to 13 deserving nonprofits that directly align with our mission,” said Erin Feigal, senior vice president and chief human resources officer and Prime Together Foundation board chair. “Thank you to all who generously donated and helped fund these grants.”
Four of the 13 organizations are inaugural 2021 Foundation grant recipients: The Bridge for Youth, Dakota Child and Family Clinic, Hennepin Healthcare Foundation and Jeremiah Program.
The full list of 2022 Foundation grant recipients includes:
- Achieve Twin Cities
- Avivo
- The Bridge for Youth
- Casa Esperanza, Inc.
- Children’s Advocacy Center of Collin County
- Connections to Independence
- Dakota Child and Family Clinic
- EVOLVE Family Services
- Hennepin Healthcare Foundation
- Jeremiah Program
- The Link
- Living Well Disability Services
- Tubman
Follow and consider engaging with the Prime Together Foundation and its work.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion